Healthcare provider profile · identity verified

Rita M. Hyde, M.D.

Internal Medicine · WESTWOOD, KS · NPI 1790701084

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	903	255
Losartan Potassium	Losartan Potassium	541	159
Rosuvastatin Calcium	Rosuvastatin Calcium	503	138
Levothyroxine Sodium	Levothyroxine Sodium	489	131
Amlodipine Besylate	Amlodipine Besylate	342	105
Omeprazole	Omeprazole	236	72
Hydrochlorothiazide	Hydrochlorothiazide	204	65
Metoprolol Succinate	Metoprolol Succinate	194	52
Pantoprazole Sodium	Pantoprazole Sodium	143	47
Synthroid	Levothyroxine Sodium	141	38
Gabapentin	Gabapentin	135	35
Alendronate Sodium	Alendronate Sodium	124	33
Sertraline Hcl	Sertraline Hcl	123	36
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	122	36
Zolpidem Tartrate	Zolpidem Tartrate	117	30
Ezetimibe	Ezetimibe	115	37
Spironolactone	Spironolactone	107	36
Trazodone Hcl	Trazodone Hcl	103	35
Eliquis	Apixaban	101	24
Lisinopril	Lisinopril	100	29
Escitalopram Oxalate	Escitalopram Oxalate	95	33
Ozempic	Semaglutide	93	15
Potassium Chloride	Potassium Chloride	91	33
Carvedilol	Carvedilol	84	23
Citalopram Hbr	Citalopram Hydrobromide	84	28
Alprazolam	Alprazolam	83	29
Jardiance	Empagliflozin	83	19
Metformin Hcl	Metformin Hcl	83	27
Famotidine	Famotidine	81	26
Metformin Hcl Er	Metformin Hcl	76	22
Duloxetine Hcl	Duloxetine Hcl	75	23
Tramadol Hcl	Tramadol Hcl	67	20
Estradiol	Estradiol	65	32
Meloxicam	Meloxicam	65	24
Montelukast Sodium	Montelukast Sodium	63	18
Ibandronate Sodium	Ibandronate Sodium	60	17
Fluticasone Propionate	Fluticasone Propionate	59	23
Irbesartan	Irbesartan	53	15
Lamotrigine	Lamotrigine	53	suppressed
Valsartan	Valsartan	52	11
Pravastatin Sodium	Pravastatin Sodium	48	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	12
Bupropion Xl	Bupropion Hcl	43	15
Furosemide	Furosemide	43	17
Albuterol Sulfate Hfa	Albuterol Sulfate	38	14
Clonazepam	Clonazepam	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	suppressed
Paroxetine Hcl	Paroxetine Hcl	36	11
Tizanidine Hcl	Tizanidine Hcl	35	11
Arexvy	Rsvpref3 Antigen/As01e/Pf	34	34
Mirtazapine	Mirtazapine	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	26
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	29	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	28	suppressed
Mounjaro	Tirzepatide	27	suppressed
Temazepam	Temazepam	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	14
Glimepiride	Glimepiride	26	suppressed
Valacyclovir	Valacyclovir Hcl	25	14
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Raloxifene Hcl	Raloxifene Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	16
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Allopurinol	Allopurinol	21	suppressed
Atenolol	Atenolol	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	14
Tamsulosin Hcl	Tamsulosin Hcl	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Levoxyl	Levothyroxine Sodium	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Bupropion Hcl	Bupropion Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Acyclovir	Acyclovir	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Ramipril	Ramipril	16	suppressed
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Acebutolol Hcl	Acebutolol Hcl	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Amoxicillin	Amoxicillin	14	12
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Dotti	Estradiol	14	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	14	suppressed
Naproxen	Naproxen	14	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Simvastatin	Simvastatin	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Estradiol (Twice Weekly)	Estradiol	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Topiramate	Topiramate	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Clopidogrel	Clopidogrel Bisulfate	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Risperidone	Risperidone	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error